Skip to content
Home/Companies/Biotech/Zealand Pharma
Zealand Pharma

Zealand Pharma

Biotech·Denmark·Exited 2017·Held 5yr
Entry
2012
Hold
5yr
Exit
2017

Who owns Zealand Pharma?

Zealand Pharma is a Danish Biotech company, formerly owned by Eurazeo, exited in 2017. No current private equity owner is on file.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Eurazeo
Investor
Eurazeo
Kurma Biofund III · 2017 · Healthcare

Key facts

HQDenmark
SectorBiotech
Websitewww.zealandpharma.com
Exit Year
2017

More from Kurma Biofund III

Other portfolio companies in the same fund.

ImCheck
ImCheck
3.0xExited 2025
BiotechFrance· 2020
to Ipsen
Amolyt Pharma
Amolyt Pharma
4.0xExited 2024
BiotechFrance· 2019
to AstraZeneca
Ermium
Ermium
Active
BiotechFrance· 2019
IO Biotech
IO Biotech
Active
BiotechDenmark· 2019
Pharvaris
Pharvaris
Active
BiotechNetherlands· 2019
Vivet
Vivet
Active
BiotechFrance· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Zealand Pharma?

Zealand Pharma was formerly owned by Eurazeo, exited in 2017. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue